AstraZeneca axes another 7,300 jobs worldwide

 


The pharmaceuticals industry was dealt a fresh blow today after AstraZeneca announced a further 7,300 job cuts amid warnings that its profits will slide this year.

The UK's second biggest drugs maker, which has 61,000 staff globally, said it was too early to say how many of its 8,000 staff in the UK would be affected.

It has already cut 21,600 staff globally since 2007 as part of two previous restructuring initiatives, including the closure of a site at Charnwood near Loughborough at the end of last year.

Unions have said that 250 to 300 of the latest cuts will be in research and development at the firm's site in Alderley Park, Cheshire, while there would be further back office cuts at other UK sites.

Its other sites in the UK are at Macclesfield, Cambridge, Luton, Avlon near Bristol, Paddington in London, and Brixham in Devon.

The latest round of cuts comes a year after rival Pfizer said it would pull the plug on its plant in Sandwich, Kent, which employed 2,400 staff.

The pharmaceuticals industry has come under pressure because its major players have struggled to invent new blockbuster drugs as patents on existing best sellers expire, leaving them open to cheap competition. Governments are also looking to reduce the prices they charge.

The industry's problems are a particular worry for the UK, which is a world leader in the field. Some 67,000 people work in the industry in the UK, of which more than a third are in research and development.

The Government, which hopes manufacturers will spearhead the recovery, has introduced lower taxes on patents to try to encourage companies to carry out more research in the UK.

Allan Black, GMB national officer for pharmaceuticals, said: "These cutting-edge research and development jobs are both well-paid and essential for a thriving UK economy.

"As a nation we do need to find a viable way to continue to make breakthroughs in bringing to safe use much-needed new medicines."

The jobs blow came as the Cheshire-based company announced a 2 per cent fall in revenues to 33.3 billion US dollars (£21.1 billion) in 2011, while profits fell 4 per cent to 13.2 billion US dollars (£8.4 billion).

Shares were down 3 per cent as the company warned that revenues for 2012 are likely to be down by more than 10 per cent while its margins will also be squeezed, leading to lower profits.

The Anglo-Swedish company has suffered a number of setbacks in its efforts to secure approval for new blockbuster drugs.

It recently warned that profits would be at the low end of analysts' expectations after ovarian cancer drug olaparib was held back for further development when tests proved it was unlikely to prove effective.

The results of tests on drugs for patients with major depressive disorders were disappointing so far, and the US Food and Drug Administration recently declined approval of a new diabetes drug dapagliflozin.

Analysts have also been underwhelmed by sales of its new blood thinning drug Brilinta.

In addition, its anti-psychotic drug Seroquel will lose exclusivity in the United States and many European countries this year.

Astra warned that the coming years would be "challenging for the industry and for the company".

Chief executive David Brennan said: "Disciplined execution of our strategy has delivered a good performance in 2011 in the face of intensified pricing pressure and generic competition.

"While the further expected losses of market exclusivity make for a challenging 2012 outlook, we remain committed to a long-term, focused, research and development based strategy, and today we have announced further steps to drive productivity in all areas to improve returns on our investment in innovation."

Despite the cost-cutting measures announced today, it announced a 10 per cent hike in its dividend and plans to return an additional 4.5 billion US dollars (£2.9 billion) to shareholders in 2012 on top of the 9.4 billion US dollars (£6 billion) last year.

PA

News
Ian Thorpe had Rio 2016 in his sights
people
Sport
world cup 2014A history of the third-place play-offs
News
Tommy Ramone performing at The Old Waldorf Nightclub in 1978 in San Francisco, California.
peopleDrummer Tommy was last surviving member of seminal band
Life and Style
Swimsuit, £245, by Agent Provocateur
fashion

Diving in at the deep end is no excuse for shirking the style stakes

PROMOTED VIDEO
Sport
The Mexico chief finally lets rip as his emotions get the better of him
world cup 2014
Voices
Spectators photograph the Tour de France riders as they make their way through the Yorkshire countryside
voicesHoward Jacobson: Line the streets for a cycling race? You might just as well watch a swarm of wasps
Life and Style
lifeHere's one answer to an inquisitive Reddit user's question
Life and Style
Several male celebrities have confessed to being on a diet, including, from left to right, Hugh Grant, Benedict Cumberbatch and Ryan Reynolds
...and the weight loss industry is rubbing its hands in glee
News
peopleDave Legeno, the actor who played werewolf Fenrir Greyback in the Harry Potter films, has died
Arts and Entertainment
'Eminem's recovery from substance abuse has made him a more potent performer, with physical charisma and energy he never had before'
arts + entsReview: Wembley Stadium ***
News
ebookA unique anthology of reporting and analysis of a crucial period of history
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Information Security Manager (ISO 27001, Accreditation, ITIL)

£70000 per annum: Harrington Starr: Information Security Manager (ISO 27001, A...

Biztalk - outstanding opportunity

£75000 - £85000 per annum + ex bens: Deerfoot IT Resources Limited: Biztalk Te...

Trade Desk Specialist (FIX, Linux, Windows, Network Security)

£60000 per annum: Harrington Starr: Trade Desk Specialist (FIX, Linux, Windows...

Service Desk Analyst (Windows, Active Directory, ITIL, Reuter)

£35000 per annum: Harrington Starr: Service Desk Analyst (Windows, Active Dire...

Day In a Page

A History of the First World War in 100 Moments: Peace without magnanimity - the summit in a railway siding that ended the fighting

A History of the First World War in 100 Moments

Peace without magnanimity - the summit in a railway siding that ended the fighting
Scottish independence: How the Commonwealth Games could swing the vote

Scottish independence: How the Commonwealth Games could swing the vote

In the final part of our series, Chris Green arrives in Glasgow - a host city struggling to keep the politics out of its celebration of sport
Out in the cold: A writer spends a night on the streets and hears the stories of the homeless

A writer spends a night on the streets

Rough sleepers - the homeless, the destitute and the drunk - exist in every city. Will Nicoll meets those whose luck has run out
Striking new stations, high-speed links and (whisper it) better services - the UK's railways are entering a new golden age

UK's railways are entering a new golden age

New stations are opening across the country and our railways appear to be entering an era not seen in Britain since the early 1950s
Conchita Wurst becomes a 'bride' on the Paris catwalk - and proves there is life after Eurovision

Conchita becomes a 'bride' on Paris catwalk

Alexander Fury salutes the Eurovision Song Contest winner's latest triumph
Pétanque World Championship in Marseilles hit by

Pétanque 'world cup' hit by death threats

This year's most acrimonious sporting event took place in France, not Brazil. How did pétanque get so passionate?
Whelks are healthy, versatile and sustainable - so why did we stop eating them in the UK?

Why did we stop eating whelks?

Whelks were the Victorian equivalent of the donor kebab and our stocks are abundant. So why do we now export them all to the Far East?
10 best women's sunglasses

In the shade: 10 best women's sunglasses

From luxury bespoke eyewear to fun festival sunnies, we round up the shades to be seen in this summer
Germany vs Argentina World Cup 2014: Lionel Messi? Javier Mascherano is key for Argentina...

World Cup final: Messi? Mascherano is key for Argentina...

No 10 is always centre of attention but Barça team-mate is just as crucial to finalists’ hopes
Siobhan-Marie O’Connor: Swimmer knows she needs Glasgow joy on road to Rio

Siobhan-Marie O’Connor: Swimmer needs Glasgow joy on road to Rio

18-year-old says this month’s Commonwealth Games are a key staging post in her career before time slips away
The true Gaza back-story that the Israelis aren’t telling this week

The true Gaza back-story that the Israelis aren’t telling this week

A future Palestine state will have no borders and be an enclave within Israel, surrounded on all sides by Israeli-held territory, says Robert Fisk
A History of the First World War in 100 Moments: The German people demand an end to the fighting

A History of the First World War in 100 Moments

The German people demand an end to the fighting
New play by Oscar Wilde's grandson reveals what the Irish wit said at his trials

New play reveals what Oscar Wilde said at trials

For a century, what Wilde actually said at his trials was a mystery. But the recent discovery of shorthand notes changed that. Now his grandson Merlin Holland has turned them into a play
Can scientists save the world's sea life from

Can scientists save our sea life?

By the end of the century, the only living things left in our oceans could be plankton and jellyfish. Alex Renton meets the scientists who are trying to turn the tide
Richard III, Trafalgar Studios, review: Martin Freeman gives highly intelligent performance

Richard III review

Martin Freeman’s psychotic monarch is big on mockery but wanting in malice